Literature DB >> 15888743

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).

E Felip1, R A Stahel, N Pavlidis.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15888743     DOI： 10.1093/annonc/mdi821

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  29 in total

1.  Current status of postoperative follow-up for lung cancer in Japan: questionnaire survey by the Setouchi Lung Cancer Study Group-A0901.

Authors:  Shigeki Sawada; Hiroshi Suehisa; Motohiro Yamashita; Masao Nakata; Norihito Okumura; Kazunori Okabe; Hiroshige Nakamura; Hirohito Tada; Shinichi Toyooka; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-02-12

2.  Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer.

Authors:  Yi-Ming Hu; Jing Li; Li-Chao Yu; Shun-Bing Shi; Yong-Jie Du; Jian-Nong Wu; Wei Lin Shi
Journal:  Pathol Oncol Res       Date:  2014-07-01       Impact factor: 3.201

Review 3.  A proposal of postoperative follow-up pathways for lung cancer.

Authors:  Shigeki Sawada; Satoshi Shiono; Yoshinori Yamashita; Tsutomu Tagawa; Hiroyuki Ito; Toshihiko Sato; Hiroaki Harada; Motohiro Yamashita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-12-18

4.  Pattern of Imaging after Lung Cancer Resection. 1992-2005.

Authors:  Gulshan Sharma; Shawn P E Nishi; Yu-Li Lin; Yong-Fang Kuo; James S Goodwin; Taylor S Riall
Journal:  Ann Am Thorac Soc       Date:  2016-09

5.  The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry.

Authors:  Rob G Stirling; S M Evans; P McLaughlin; M Senthuren; J Millar; J Gooi; L Irving; P Mitchell; A Haydon; J Ruben; M Conron; T Leong; N Watkins; J J McNeil
Journal:  Lung       Date:  2014-06-08       Impact factor: 2.584

6.  EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study.

Authors:  Ramon Andrade de Mello; Filipa Soares Pires; Dânia Sofia Marques; Júlio Oliveira; Ana Rodrigues; Marta Soares; Isabel Azevedo; Ana Peixoto; Catarina Santos; Carla Pinto; Venceslau Hespanhol; Manuel R Teixeira; Teresina Amaro; Henrique Queiroga; António Araújo
Journal:  Tumour Biol       Date:  2012-07-29

7.  Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.

Authors:  Sushravya Raghunath; Fabien Maldonado; Srinivasan Rajagopalan; Ronald A Karwoski; Zackary S DePew; Brian J Bartholmai; Tobias Peikert; Richard A Robb
Journal:  J Thorac Oncol       Date:  2014-11       Impact factor: 15.609

8.  Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC).

Authors:  Sharon Glaysher; Dennis Yiannakis; Francis G Gabriel; Penny Johnson; Marta E Polak; Louise A Knight; Zoe Goldthorpe; Katharine Peregrin; Mya Gyi; Paul Modi; Joe Rahamim; Mark E Smith; Khalid Amer; Bruce Addis; Matthew Poole; Ajit Narayanan; Tim J Gulliford; Peter E Andreotti; Ian A Cree
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

9.  Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients.

Authors:  Jing Li; Chun-Hua Dai; Shun-Bing Shi; Ping Chen; Li-Chao Yu; Jian-Rong Wu
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

10.  Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapy.

Authors:  Chuangzhou Rao; Qiongge Hu; Jianhua Ma; Jian Li; Chen Zhang; Li Shen; Qichun Wei
Journal:  J Exp Clin Cancer Res       Date:  2010-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.